Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissueTomomi Hirama, Toshihiko Torigoe|JCI Insight|2021Cited by 33
Crisscross CTL Induction by SYT-SSX Junction Peptide and Its HLA-A*2402 Anchor SubstituteKazunori Ida, Noriyuki Sato, Yuriko Sato et al.|The Journal of Immunology|2004Cited by 32
Cisplatin‐induced <scp>HSF1‐HSP90</scp> axis enhances the expression of functional <scp>PD‐L1</scp> in oral squamous cell carcinomaTakashi Sasaya, Toshihiko Torigoe|Cancer Medicine|2022Cited by 23
HLA class II neoantigen presentation for CD4 <sup>+</sup> T cell surveillance in HLA class II-negative colorectal cancerSatoru Matsumoto, Toshihiko Torigoe|OncoImmunology|2024Cited by 5